This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Jan 19;359(9302):263; author reply 264.

doi: 10.1016/S0140-6736(02)07428-7.

Peginterferon alfa-2b plus ribavirin for chronic hepatitis

Miguel Santin, Evelyn Shaw

PMID: 11812596
DOI: 10.1016/S0140-6736(02)07428-7

Comment

Peginterferon alfa-2b plus ribavirin for chronic hepatitis

Miguel Santin et al. Lancet. 2002.

. 2002 Jan 19;359(9302):263; author reply 264.

doi: 10.1016/S0140-6736(02)07428-7.

Authors

Miguel Santin, Evelyn Shaw

PMID: 11812596
DOI: 10.1016/S0140-6736(02)07428-7

No abstract available

PubMed Disclaimer

Comment on

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Manns MP, et al. Lancet. 2001 Sep 22;358(9286):958-65. doi: 10.1016/s0140-6736(01)06102-5. Lancet. 2001. PMID: 11583749 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science